We have dedicated our lives to giving patients back theirs.
Providing the freedom of self-injectable care to patients who rely on intravenous (“IV”) biologics.
Millions of patients with significant disease spend day after day at an infusion center, with an IV in their arm. It’s painful, time-consuming and costly for everyone involved. Living with disease doesn’t have to be this challenging.
We’ve set out to maximize the true potential of life-changing biologics by empowering patients to administer their own medicine via a single, simple injection, wherever they feel most comfortable.
“I no longer feel like I live at the hospital.”
We’re transforming biologics from IV to SQ.
Many biologic medicines must be administered intravenously and require multiple, hours-long dosing regimens. While subcutaneous (“SQ”) injections are preferred, biologic formulations are often either too viscous to flow easily through a fine-gauge needle or are too unstable in a concentrated form.
Our innovative platform, SQore™, addresses formulation challenges through novel, patented excipients that may improve ease of administration without compromising efficacy or tolerability.
Leveraging SQore, we are collaborating with pharmaceutical and biotechnology companies to enhance the delivery of their biologic medicines and developing an internal portfolio of proprietary SQ therapeutics.
Stand with us as we change patient realities.
Looking for people with expertise in formulation science, therapeutic protein technology and development. With enough compassion and tenacity to inspire breakthrough innovation. With as much interest in patients as they have in progress.